Syn2Psy is an Innovative Training Network (ITN) funded by the EU Horizon 2020 framework program under the Marie Sklodowska-Curie Actions (MSCA) initiative. Its mission is to provide advanced (PhD-level) training to early-stage researchers in the molecular, synaptic, circuit and behaviour basis of neuropsychiatric disorders.

Latest Posts

Syn2Psy Blog Series II

Email exchange between ESRs

by Elisa Corti and Ágata Silván

Pfizer Award - Joao Peca
João Peça recieved a Pfizer Prize for the work on genes associated with Autism Spectrum Disorders. The group studied the physiological roles of GPRASP2 (G Protein-Coupled Receptor Associated Sorting Protein 2) by creating Gprasp2 mutant mice which displayed autism-like behaviour.

News from the lab





Neuropsychiatric disorders represent one of the greatest medical and societal challenges of the 21st century, being the leading cause of years lived with disability worldwide. In order to develop better therapeutic strategies, a new mindset approach to preparing the next generation of researchers in the field must be adopted, and Syn2Psy is embracing it.

Syn2Psy Blog Series I

Diary of an Early Stage Researcher

by Manuela Rizzi

Kick-off Meeting

Coimbra, 26-27 September 2019

Network School 1

Basic Concepts on Imaging Tools and Data Analysis

Coimbra, 30 September – 4 October

Top-level academic / non-academic european institutions













Partner organizations